Early Phase Decision Making About Cognitive Safety
September 22, 2015
The first entry in Cogstate’s podcast series – ‘Measuring Cognition in Clinical Trials’ – sees Professor Paul Maruff, Chief Scientific Officer at Cogstate, discussing methodology for measuring cognition in early phase research, as well as delving into the details of computerized cognitive tests and their impact on drug development decision making. Professor Maruff also explains how the Cogstate Brief Battery is validated and employed in both early-phase research as well as later phase studies.